These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 14506030)

  • 21. Titration of C-5 Sterol Desaturase Activity Reveals Its Relationship to Candida albicans Virulence and Antifungal Susceptibility Is Dependent upon Host Immune Status.
    Regan J; DeJarnette C; Luna-Tapia A; Parker JE; Reitler P; Barnett S; Tucker KM; Kelly SL; Palmer GE
    mBio; 2022 Apr; 13(2):e0011522. PubMed ID: 35380453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relative contributions of the Candida albicans ABC transporters Cdr1p and Cdr2p to clinical azole resistance.
    Tsao S; Rahkhoodaee F; Raymond M
    Antimicrob Agents Chemother; 2009 Apr; 53(4):1344-52. PubMed ID: 19223631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antifungal drug resistance in pathogenic fungi.
    Vanden Bossche H; Dromer F; Improvisi I; Lozano-Chiu M; Rex JH; Sanglard D
    Med Mycol; 1998; 36 Suppl 1():119-28. PubMed ID: 9988500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of genes differentially expressed in association with reduced azole susceptibility in Saccharomyces cerevisiae.
    Barker KS; Pearson MM; Rogers PD
    J Antimicrob Chemother; 2003 May; 51(5):1131-40. PubMed ID: 12697649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced azole susceptibility in genotype 3 Candida dubliniensis isolates associated with increased CdCDR1 and CdCDR2 expression.
    Pinjon E; Jackson CJ; Kelly SL; Sanglard D; Moran G; Coleman DC; Sullivan DJ
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1312-8. PubMed ID: 15793103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new triazole, voriconazole (UK-109,496), blocks sterol biosynthesis in Candida albicans and Candida krusei.
    Sanati H; Belanger P; Fratti R; Ghannoum M
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2492-6. PubMed ID: 9371355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergistic antifungal activity of statin-azole associations as witnessed by Saccharomyces cerevisiae- and Candida utilis-bioassays and ergosterol quantification.
    Cabral ME; Figueroa LI; Fariña JI
    Rev Iberoam Micol; 2013 Jan; 30(1):31-8. PubMed ID: 23069981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors.
    Sanglard D; Ischer F; Monod M; Bille J
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2300-5. PubMed ID: 8891134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Candida dubliniensis CdCDR1 gene is not essential for fluconazole resistance.
    Moran G; Sullivan D; Morschhäuser J; Coleman D
    Antimicrob Agents Chemother; 2002 Sep; 46(9):2829-41. PubMed ID: 12183235
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Nishimoto AT; Wiederhold NP; Flowers SA; Zhang Q; Kelly SL; Morschhäuser J; Yates CM; Hoekstra WJ; Schotzinger RJ; Garvey EP; Rogers PD
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30910896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Candida glabrata putative sterol transporter gene CgAUS1 protects cells against azoles in the presence of serum.
    Nakayama H; Tanabe K; Bard M; Hodgson W; Wu S; Takemori D; Aoyama T; Kumaraswami NS; Metzler L; Takano Y; Chibana H; Niimi M
    J Antimicrob Chemother; 2007 Dec; 60(6):1264-72. PubMed ID: 17913716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unexpected effects of azole transporter inhibitors on antifungal susceptibility in Candida glabrata and other pathogenic Candida species.
    Nagayoshi Y; Miyazaki T; Shimamura S; Nakayama H; Minematsu A; Yamauchi S; Takazono T; Nakamura S; Yanagihara K; Kohno S; Mukae H; Izumikawa K
    PLoS One; 2017; 12(7):e0180990. PubMed ID: 28700656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Missense mutation in CgPDR1 regulator associated with azole-resistant Candida glabrata recovered from Thai oral candidiasis patients.
    Tantivitayakul P; Lapirattanakul J; Kaypetch R; Muadcheingka T
    J Glob Antimicrob Resist; 2019 Jun; 17():221-226. PubMed ID: 30658200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adenylyl Cyclase and Protein Kinase A Play Redundant and Distinct Roles in Growth, Differentiation, Antifungal Drug Resistance, and Pathogenicity of
    Kim JS; Lee KT; Lee MH; Cheong E; Bahn YS
    mBio; 2021 Oct; 12(5):e0272921. PubMed ID: 34663094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic Analysis of
    Kim SH; Iyer KR; Pardeshi L; Muñoz JF; Robbins N; Cuomo CA; Wong KH; Cowen LE
    mBio; 2019 Jan; 10(1):. PubMed ID: 30696744
    [No Abstract]   [Full Text] [Related]  

  • 36. Amino acid substitutions in the cytochrome P-450 lanosterol 14alpha-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents.
    Sanglard D; Ischer F; Koymans L; Bille J
    Antimicrob Agents Chemother; 1998 Feb; 42(2):241-53. PubMed ID: 9527767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multidrug Transporters and Alterations in Sterol Biosynthesis Contribute to Azole Antifungal Resistance in Candida parapsilosis.
    Berkow EL; Manigaba K; Parker JE; Barker KS; Kelly SL; Rogers PD
    Antimicrob Agents Chemother; 2015 Oct; 59(10):5942-50. PubMed ID: 26169412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance.
    Chowdhary A; Prakash A; Sharma C; Kordalewska M; Kumar A; Sarma S; Tarai B; Singh A; Upadhyaya G; Upadhyay S; Yadav P; Singh PK; Khillan V; Sachdeva N; Perlin DS; Meis JF
    J Antimicrob Chemother; 2018 Apr; 73(4):891-899. PubMed ID: 29325167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of visual and spectrophotometric methods of broth microdilution MIC end point determination and evaluation of a sterol quantitation method for in vitro susceptibility testing of fluconazole and itraconazole against trailing and nontrailing Candida isolates.
    Arthington-Skaggs BA; Lee-Yang W; Ciblak MA; Frade JP; Brandt ME; Hajjeh RA; Harrison LH; Sofair AN; Warnock DW;
    Antimicrob Agents Chemother; 2002 Aug; 46(8):2477-81. PubMed ID: 12121921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crystal Structures of Full-Length Lanosterol 14α-Demethylases of Prominent Fungal Pathogens Candida albicans and Candida glabrata Provide Tools for Antifungal Discovery.
    Keniya MV; Sabherwal M; Wilson RK; Woods MA; Sagatova AA; Tyndall JDA; Monk BC
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.